Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Statistics in Medicine|October 31, 2024
Dose Individualization for Phase I Cancer Trials With Broadened EligibilityRebecca B Silva, Bin Cheng, Richard D Carvajal, et al.
Oncology (Williston Park, N.Y.)|January 22, 2016
Clinical Management of Uveal and Conjunctival MelanomaElyse S Blum, Jessica Yang, Kimberly M Komatsubara, et al.
Journal for Immunotherapy of Cancer|October 29, 2014
Ipilimumab in patients with melanoma and autoimmune diseaseChrisann Kyi, Richard D Carvajal, Jedd D Wolchok, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
Dual checkpoint inhibitor-associated eosinophilic enteritisJ Yang, S M Lagana, Y M Saenger, et al.
Expert Opinion on Biological Therapy|January 21, 2022
Tebentafusp in advanced uveal melanoma: proof of principle for the efficacy of T-cell receptor therapeutics and bispecifics in solid tumorsAlex W Liu, Alexander Z Wei, Ashray B Maniar, et al.
Oncology (Williston Park, N.Y.)|November 28, 2017
Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive DiseaseBenjamin A Lerner, Latoya A Stewart, David P Horowitz, et al.
International Journal of Surgery Case Reports|January 5, 2021
Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanomaYonatan Dollin, Jason Rubin, Richard D Carvajal, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Surveillance options for patients with uveal melanoma following definitive managementJasmine H Francis, Sapna P Patel, Dan S Gombos, et al.
Pageof 22